Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Bardet-Biedl Syndrome
- A Phase 3 Crossover Trial of Two Formulations of Setmelanotide in Patients With Specific Gene Defects in the Melanocortin-4 Receptor Pathway
- Pediatric Rare Genetic Causes of Obesity
- Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) Patients With Moderate to Severe Obesity
- Treatment of Bardet-Biedl-Syndrome With Metformin for Evaluation of a Possible Visual Improvement
- Setmelanotide Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity